Clincosm LogoSign in Get a demo

Treatment-resistant Depression

Showing 1 - 25 of 27
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Treatment-Resistant Depression Trial (Active rTMS with short inter-session interval, Sham rTMS with short inter-session

Not yet recruiting
  • Treatment-Resistant Depression
  • Active rTMS with short inter-session interval
  • +2 more
  • (no location specified)
Apr 24, 2023

Treatment-resistant Depression Trial in Galway (GH001, Placebo)

Recruiting
  • Treatment-resistant Depression
  • Galway, Ireland
    Investigational Site
Apr 5, 2023

Treatment-Resistant Depression Trial in Hangzhou (non-invasive transcranial deep brain stimulation, Sham stimulation, Motor

Recruiting
  • Treatment-Resistant Depression
  • non-invasive transcranial deep brain stimulation
  • +3 more
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital of Zhejiang University
Mar 8, 2023

Treatment-resistant Depression Trial in Toronto (Psilocybin 25 mg, Risperidone 1 MG, Placebo)

Not yet recruiting
  • Treatment-resistant Depression
  • Psilocybin 25 mg
  • +2 more
  • Toronto, Ontario, Canada
    Centre for Addiction and Mental Health
Feb 2, 2023

MDD, Treatment-Resistant Depression, Depression Trial run by the NIMH (Placebo, TS-161 (50 - 100 mg))

Recruiting
  • Major Depressive Disorder
  • +2 more
  • Placebo
  • TS-161 (50 - 100 mg)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Treatment-resistant Depression Trial in Hangzhou (active iTBS, sham rTMS)

Recruiting
  • Treatment-resistant Depression
  • active iTBS
  • sham rTMS
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital of Zhejiang University
Jan 12, 2023

Treatment-resistant Depression Trial (Non-invasive brain stimulation protocol (intermittent theta burst protocol (iTBS))

Not yet recruiting
  • Treatment-resistant Depression
  • Non-invasive brain stimulation protocol (intermittent theta burst protocol (iTBS)) combined with pleasant odors delivered during the iTBS procol.
  • Non-invasive brain stimulation protocol (intermittent theta burst protocol (iTBS)) delivered alone.
  • (no location specified)
Dec 13, 2022

Treatment-resistant Depression Trial in Freiburg, Bonn (Vercise GEVIA deep brain stimulation (DBS) system)

Recruiting
  • Treatment-resistant Depression
  • Vercise GEVIA deep brain stimulation (DBS) system
  • Grenoble, France
  • +1 more
Nov 2, 2022

Treatment-resistant Depression Trial in France (Systematic maintenance rTMS, rTMS course in case of relapse, sham rTMS)

Active, not recruiting
  • Treatment-resistant Depression
  • Systematic maintenance rTMS
  • +2 more
  • Angers, France
  • +18 more
Sep 15, 2022

Suicidal Ideation, Treatment-resistant Depression Trial in San Diego (Accelerated Theta Burst Stimulation)

Recruiting
  • Suicidal Ideation
  • Treatment-resistant Depression
  • Accelerated Theta Burst Stimulation
  • San Diego, California
    UCSD Interventional Psychiatry
Sep 9, 2022

Treatment-resistant Depression, MDD Trial in Taipei (Prolonged intermittent theta burst stimulation (piTBS), 20Hz rTMS, sham

Recruiting
  • Treatment-resistant Depression
  • Major Depressive Disorder
  • Prolonged intermittent theta burst stimulation (piTBS)
  • +2 more
  • Taipei, Taiwan
    Taipei Veterans General Hospital, Taiwan
Aug 15, 2022

Treatment-Resistant Depression Trial (MIJ821 Subcutaneous Injection - low dose, MIJ821 Subcutaneous Injection - medium dose,

Not yet recruiting
  • Treatment-Resistant Depression
  • MIJ821 Subcutaneous Injection - low dose
  • +3 more
  • (no location specified)
Jul 8, 2022

Ketamine on Neurological Activity as Measured by

Recruiting
  • Treatment-resistant Depression
  • Observational - no intervention
  • Austin, Texas
    Heading Health
Jun 17, 2022

Late-life Depression, Treatment-resistant Depression Trial in London (Sahaj Samadhi Meditation (SSM), Health Enhancement Program

Terminated
  • Late-life Depression
  • Treatment-resistant Depression
  • Sahaj Samadhi Meditation (SSM)
  • Health Enhancement Program (HEP)
  • London, Ontario, Canada
    London Health Sciences Centre
Apr 12, 2022

Treatment-resistant Depression, MDD Trial in Taipei city (Midazolam (active ), Ketamine and Midazolam (active ), Ketamine)

Recruiting
  • Treatment-resistant Depression
  • Major Depressive Disorder
  • Midazolam (active placebo)
  • +2 more
  • Taipei city, Taiwan
    Taipei Veterans General Hospital, Taiwan
Apr 1, 2022

Persistent Depressive Disorder, Treatment-resistant Depression Trial in Germany (inpatient CBASP individual therapy, inpatient

Not yet recruiting
  • Persistent Depressive Disorder
  • Treatment-resistant Depression
  • inpatient CBASP individual therapy
  • +10 more
  • Berlin, Germany
  • +5 more
Aug 25, 2021

Treatment-resistant Depression Trial in Berlin, Mannheim (Psilocybin, Nicotinamide)

Recruiting
  • Treatment-resistant Depression
  • Berlin, Germany
  • +1 more
Jul 28, 2021

Treatment-resistant Depression Trial in Taipei (Nurse-led cognitive-behavioral-based group intervention)

Completed
  • Treatment-resistant Depression
  • Nurse-led cognitive-behavioral-based group intervention
  • Taipei, Taiwan
    Chia-Yi Wu
May 6, 2021

Treatment-resistant Depression Trial in Worldwide (Esketamine, Placebo, Duloxetine (Oral Antidepressant))

Completed
Has Results
  • Treatment-resistant Depression
  • Birmingham, Alabama
  • +49 more
May 18, 2020

Treatment-resistant Depression Trial in Worldwide (Esketamine (Intranasal Spray), Duloxetine (Oral Antidepressant), Escitalopram

Completed
Has Results
  • Treatment-resistant Depression
  • Esketamine (Intranasal Spray)
  • +4 more
  • New Haven, Connecticut
  • +109 more
Apr 27, 2020

Treatment-resistant Depression Trial in Worldwide (Esketamine, Placebo, Duloxetine (Oral Antidepressant))

Completed
Has Results
  • Treatment-resistant Depression
  • Birmingham, Alabama
  • +90 more
Apr 17, 2020

Treatment-resistant Depression Trial in Ottawa (Ketamine, Midazolam)

Completed
  • Treatment-resistant Depression
  • Ottawa, Ontario, Canada
    Institute of Mental Health Research, Royal Ottawa Hospital
Jun 22, 2018

Treatment-Resistant Depression Trial (TAK-653, Placebo)

Withdrawn
  • Treatment-Resistant Depression
  • (no location specified)
Feb 20, 2018

Treatment-Resistant Depression Trial (Deep Brain Stimulation)

Unknown status
  • Treatment-Resistant Depression
  • Deep Brain Stimulation
  • (no location specified)
Oct 13, 2016

Treatment-Resistant Depression Trial in Beirut (Focal Electrically Administered Seizure Therapy)

Unknown status
  • Treatment-Resistant Depression
  • Focal Electrically Administered Seizure Therapy
  • Beirut, Lebanon
    American University of Beirut Medical Center
Apr 5, 2016